Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Heviz – page 8

129 clinical trials in Heviz, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Heviz at a glance
129
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

129 trials in Heviz

Open in trial search

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Astrazeneca AB

Study on the Effects of FDY-5301 for Patients with Anterior ST-Elevation Myocardial Infarction (Heart Attack)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide
  • Sponsor:Faraday Pharmaceuticals Inc.

Cardiac failure

Not recruiting

Study on the Effects of Ponsegromab on Quality of Life and Safety in Adults with Heart Failure

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Cardiac failure+1

Not recruiting

Study of LY3540378 for Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Volenrelaxin
  • Sponsor:Eli Lilly & Co.

A study comparing the effectiveness of vorolanib and aflibercept in patients with diabetic macular edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

A Study of XC001 Gene Therapy with Bypass Surgery for Patients with Coronary Artery Disease and Weakened Heart Function at Risk for Incomplete Treatment

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Xylocor Therapeutics Inc.

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Dermatitis atopic

Not recruiting

Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Migraine

Not recruiting

Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Rimegepant sulfate
  • Sponsor:Pfizer Inc.

Cardiac failure

Not recruiting

Study on COR-1167 for Patients with Worsening Heart Failure

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:COR-1167 sodium
  • Sponsor:Corteria Pharmaceuticals

Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:EYE103
  • Sponsor:Eyebiotech Limited

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Heviz

What the registry says about research in the country

01 Rheumatology Research

Clinical investigations focusing on rheumatoid arthritis treatments, comparing the effectiveness of different therapeutic approaches for patients who haven't responded adequately to conventional treatments.

  • Treatment Comparison Studies
  • Disease Management
  • Therapeutic Innovation

Research aims to evaluate new treatment options for patients with moderate to severe rheumatoid arthritis, examining both symptom management and disease progression prevention.

02 Inflammatory Conditions

Comprehensive research examining advanced therapies for inflammatory disorders, with a particular focus on autoimmune conditions affecting joint health and mobility.

  • Autoimmune Disease Research
  • Long-term Treatment Efficacy
  • Patient Response Evaluation

Studies assess the safety and effectiveness of innovative treatments compared to existing therapeutic options.

03 Treatment Optimization

Investigation of combination therapy approaches for patients who have shown inadequate response to standard treatments, exploring new pathways for enhanced therapeutic outcomes.

  • Drug Comparison Studies
  • Treatment Safety Assessment
  • Long-term Effectiveness

Research focuses on optimizing treatment strategies for patients with resistant forms of inflammatory arthritis.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.